Evidence method
Level · gp.fundamentals.capex_revenue_ratio
7.53% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
LCTX · Dec 31, 2023
Lineage Cell Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000950170-24-027988General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-319.35% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
-39.16% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
92.50% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-276.50% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
175.57% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
51.87% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/5 normalizedLevel 3Dec 31, 20220/6 normalizedLevel 3Mar 31, 20230/6 normalizedLevel 3Jun 30, 20230/6 normalizedLevel 3Sep 30, 20230/7 normalizedLevel 3Dec 31, 20230/7 normalizedLevel 3Mar 31, 20240/6 normalizedLevel 3Jun 30, 20240/6 normalizedLevel 3Sep 30, 20244/6 normalizedLevel 3Dec 31, 20245/6 normalizedLevel 3Mar 31, 20255/6 normalizedLevel 3Jun 30, 20255/6 normalizedLevel 3Sep 30, 20256/6 normalizedLevel 3Dec 31, 20256/6 normalizedLevel 3Mar 31, 20266/6 normalizedLevel 3Jun 30, 20266/6 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 11.16%
- Current
- 7.53%
- Delta
- -3.62%
- Previous
- -404.25%
- Current
- -319.35%
- Delta
- 84.90%
- Previous
- -58.44%
- Current
- -39.16%
- Delta
- 19.28%
- Previous
- 86.44%
- Current
- 92.50%
- Delta
- 6.06%
- Previous
- -538.12%
- Current
- -276.50%
- Delta
- 261.62%
- Previous
- 300.24%
- Current
- 175.57%
- Delta
- -124.67%
- Previous
- 101.85%
- Current
- 51.87%
- Delta
- -49.97%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · LCTX Fundamental State →Transitioned To · LCTX MARGIN_INCREASED →Transitioned To · LCTX PROFITABILITY_INCREASED →Transitioned To · LCTX R_AND_D_INTENSITY_DECREASED →Transitioned To · LCTX SBC_INTENSITY_DECREASED →Transitioned To · LCTX Fundamental State →Transitioned To · LCTX CAPEX_INTENSITY_DECREASED →Transitioned To · LCTX CASH_GENERATION_INCREASED →Transitioned To · LCTX GROWTH_INCREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.